Swine | Boehringer Ingelheim

Swine

Pig production costs are rising. Labor is tight. Infectious diseases continue to threaten, while market conditions are in constant flux. In the face of these uncertainties, pork producers turn to our global network of swine health experts for effective vaccines and big-picture strategies to sustain their businesses for the long term.

Evolving disease threats affect both pigs and the farmers who raise them. Preventive measures such as vaccination and biosecurity are essential to limit disease spread and secure pig health and animal protein supply. With longstanding experience and leading vaccines, we help farmers keep their pig herds thriving and offer ongoing education and insights on critical swine health and industry issues.

Animal vaccines are a lynchpin of global food security

Did you know that roughly 25% of livestock in developing countries die each year of preventable diseases? And worldwide, uncontrolled disease outbreaks significantly impact the food industry. Let’s take a deep dive into the critical importance of preventive vaccination to ensure food security.

Find out more

Recognizing scientific excellence: the European PRRS Research Awards

Every year, we give out the European PRRS Research Awards to fund scientific work on practical methods for battling this serious swine disease. Keep an eye out for the 2025 award winners to be announced in the fall.

Visit site

Keeping 27 billion livestock disease-free is a big responsibility

Protecting the health of cattle, pigs, chickens, and other livestock worldwide protects food supplies, public health, and economic systems. Dr. Armin Wiesler, Head of our Animal Health Business Unit, offers his perspective on these critical issues.

Find out more

Biosecurity: a critical measure against African swine fever

While not a danger to human health, the rapid spread and high fatality of African swine fever (ASF) is a major threat to pig health and the economy. As we work to develop a vaccine against this challenging virus, Boehringer provides biosecurity guidance and tools to help protect pigs from ASF and other infectious threats.

Read more

Defend your pigs against PRRS and ASF: essential biosecurity tips

Learn how to protect your pigs from Porcine Reproductive and Respiratory Syndrome and African Swine Fever.

Defend your pigs against PRRS and ASF: essential biosecurity tips

Knowing the enemy: PRRS and PCVD

How can farmers effectively protect their pigs? Find out here.

Knowing the enemy: PRRS and PCVD

Explore the latest research, expert perspectives, actionable tools, and more to help swine producers stay ahead of PRRS.

There are no quick fixes to most of the enteric, respiratory, and reproductive pathogens that erode swine producers’ profitability. Investing in preventive care—from a comprehensive herd vaccination program to surveillance and biosecurity—brings measurable returns in pig health and productivity as well as business sustainability. Boehringer’s swine experts have the data to prove it.

Explore more swine industry issues

Pig vaccines that protect the animals and the planet

What is the future of meat consumption?

Meat consumption on the rise – as are alternative proteins. What can we make of these trends?

What is the future of meat consumption?

7 facts you should know about Ileitis

Cause, impact and prevention: Learn the essentials about Ileitis

7 facts you should know about Ileitis

Rapid response against serious swine disease outbreaks

Learn how Boehringer Ingelheim’s Veterinary Public Health (VPH) experts monitor, prepare for, and deploy against highly transmissible animal diseases like foot-and-mouth disease that threaten swine health, economic systems, and global food supply.

More on transboundary diseases

From gut health to respiratory and reproductive diseases, we offer the industry’s highest quality vaccines against the most serious swine infectious diseases.

See swine products

Collaboration on swine vaccine innovation

Boehringer has built longstanding partnerships with world-class research institutes to bring critical vaccines to market faster.

Pirbright Institute, UK

Friedrich Loeffler Institute, Germany

Harbin Institute, China

References